Published Online: 01 March 1989
| ||Format||Pages||Price|| |
|PDF (132K)||4||$25||  ADD TO CART|
Cite this document
A recent development in the cancer risk area is the advent of biologically based pharmacokinetic and pharmacodynamic models. These models allow for the incorporation of biological and mechanistic data into the risk assessment process. These advances will not only improve the risk assessment process for halogenated solvents but will stimulate and guide basic research in the biological area.
Office of Risk Analysis, Oak Ridge National Laboratory, Oak Ridge, TN
Stock #: JTE11099J